Story at a glance There are no monoclonal antibodies currently authorized in the U.S. to fight a SARS-CoV-2 infection. A new antiviral drug received emergency authorization in Japan and will enter global phase 3 clinical trials. A paper published today introduces a “decoy” drug that targets the virus through a novel mechanism. With no monoclonal antibody treatments available to fight the coronavirus, vulnerable populations may be at even higher risk this winter as COVID-19 cases start rising after the Thanksgiving holiday. There aren’t currently any monoclonal antibodies on the horizon to replace those that the Food and Drug Administration (FDA) has revoked aut
Hence then, the article about two new drugs could fight covid 19 was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Two new drugs could fight COVID-19 )